Yan M, Brady J R, Chan B, Lee W P, Hsu B, Harless S, Cancro M, Grewal I S, Dixit V M
Department of Molecular Oncology, Genentech, South San Francisco, CA 94080, USA.
Curr Biol. 2001 Oct 2;11(19):1547-52. doi: 10.1016/s0960-9822(01)00481-x.
BLyS (also called BAFF, TALL-1, THANK, and zTNF4), a TNF superfamily member, binds two receptors, TACI and BCMA, and regulates humoral immune responses [1-7]. These two receptors also bind APRIL [7-10], another TNF superfamily member. The results from TACI(-/-) and BCMA(-/-) mice suggest the existence of additional receptor(s) for BLyS. The TACI knockout gives the paradoxical result of B cells being hyperresponsive, suggesting an inhibitory role for this receptor [11, 12], while BCMA null mice have no discernable phenotype [13]. Here we report the identification of a third BLyS receptor (BR3; BLyS receptor 3). This receptor is unique in that, in contrast to TACI and BCMA, BR3 only binds BLyS. Treatment of antigen-challenged mice with BR3-Fc inhibited antibody production, indicating an essential role for BLyS, but not APRIL, in this response. A critical role for BR3 in B cell ontogeny is underscored by our data showing that the BR3 gene had been inactivated by a discrete, approximately 4.7 kb gene insertion event that disrupted the 3' end of the BR3 gene in A/WySnJ mice, which lack peripheral B cells.
BLyS(也称为BAFF、TALL-1、THANK和zTNF4)是一种肿瘤坏死因子(TNF)超家族成员,可与两种受体TACI和BCMA结合,并调节体液免疫反应[1-7]。这两种受体也可与另一种TNF超家族成员APRIL结合[7-10]。TACI(-/-)和BCMA(-/-)小鼠的实验结果表明,可能存在其他能与BLyS结合的受体。TACI基因敲除产生了矛盾的结果,即B细胞反应过度,提示该受体具有抑制作用[11, 12],而BCMA基因敲除的小鼠没有明显的表型[13]。在此,我们报告了第三种BLyS受体(BR3;BLyS受体3)的鉴定。该受体的独特之处在于,与TACI和BCMA不同,BR3仅与BLyS结合。用BR3-Fc处理抗原刺激的小鼠可抑制抗体产生,表明在该反应中BLyS起关键作用,而APRIL并非如此。我们的数据表明,在缺乏外周B细胞的A/WySnJ小鼠中,BR3基因因一个约4.7 kb的离散基因插入事件而失活,该事件破坏了BR3基因的3'端,这突出了BR3在B细胞发育中的关键作用。